ELREXFIO (elranatamab) is the a new approved bispecific antibody for myeloma patients. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how ELREXFIO works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.
Ajay Nooka, MD, MPH, FACP | Winship Cancer Institute of Emory University
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
ELREXFIO (elranatamab) is the a new approved bispecific antibody for myeloma patients. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how ELREXFIO works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.
Ajay Nooka, MD, MPH, FACP | Winship Cancer Institute of Emory University
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
about the author
Leonardo Garcia
Leo is the video production manager for HealthTree University. He has been immersed in the field of digital media for over 15 years, and he's passionate about creating content that helps patients through their cancer journey. Leo commits to creating high quality, accurate, and easy-to-understand video lessons with the HealthTree video team.